Baseline data from the ProtecT trial … with outcomes still to come

Many readers of this blog will be interested to look through the data on the preliminary study design and diagnostic and baseline results of the randomized, phase III ProtecT trial that have just been reported in The Lancet Oncology. … READ MORE …

Robot-assisted versus open radical cystectomy: no clear signs of immediate benefit

Many readers of this blog have probably heard or read the reports like this one on the CBS Evening News or this one on the Reuters web site that there were no significant short-term (perioperative) differences in outcome between robot-assisted radical cystectomy (complete removal of the bladder) and the older open surgical procedure. … READ MORE …

ART or SRT in high-risk patients post-surgery?

As many of our regular readers will know, there is no clear answer to the question whether, among men at elevated risk of progressive disease after first-line surgery, it is better to have adjuvant radiation therapy (ART) within a few months of surgery or to wait until salvage radiation therapy (SRT) is clearly advisable. … READ MORE …

How much do you think you should pay for a radical prostatectomy?

We wish we’d seen this earlier, but apparently in March 2014 an article in Urology gave us an outstanding overview of the wildly different prices that you (but perhaps not your insurance company) might be asked to pay for a radical prostatectomy at 100 hospitals across the USA. … READ MORE …

Heterogeneity of outcomes after radical prostatectomy: the surgeon is a factor

It will come as no surprise to regular readers of this blog that there is variation among surgeons in the overall quality of their patients’ outcomes after radical prostatectomy. However, a newly published and large study of outcomes among surgeons in Sweden does expand our knowledge on this topic. … READ MORE …

Surgery vs. radiation therapy in first-line treatment of prostate cancer: a travesty

Almost exactly a year ago, we commented unfavorably on a media release issued by the European Association for Urology (EAU). The media release referred to a presentation made by Sooriakumaran et al. at the annual meeting of the EAU in 2013. … READ MORE …

The SPCG-4 trial: follow-up data after > 23 years

This week’s New England Journal of Medicine contains data from a fifth update to the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) trial of radical prostatectomy vs. watchful waiting in “early” prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,133 other followers